Search research articles
Contact Us
Filters
Showing results (91-100 of 149) with videos related to
Page
of 15
Sort By:
Pediatric Blood & Cancer
|
April 16, 2021
α4β7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host disease
Azada Ibrahimova, Stella M Davies, Adam Lane, et al.
British Journal of Clinical Pharmacology
|
April 13, 2025
The feasibility of pharmacokinetic-based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trial
Alexandra Power-Hays, Ruth Namazzi, Min Dong, et al.
Blood
|
November 14, 2022
Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa
Peter Olupot-Olupot, George Tomlinson, Thomas N Williams, et al.
Transplantation and Cellular Therapy
|
February 27, 2022
Abnormal Maximal and Submaximal Cardiopulmonary Exercise Capacity in Pediatric Stem Cell Transplant Recipients Despite Normal Standard Echocardiographic Parameters: A Pilot Study
Adam W Powell, Elaine M Urbina, Peace Madueme, et al.
Haematologica
|
December 24, 2025
Lipid dysregulation after hematopoietic stem cell transplant
Jane Koo, Lucille Langenberg, Xueheng Zhao, et al.
British Journal of Haematology
|
July 22, 2021
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial
Angela Rankine-Mullings, Marvin Reid, Deanne Soares, et al.
Translational Oncology
|
January 1, 2018
Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell Carcinoma
Trisha Wise-Draper, Arun Sendilnathan, Sarah Palackdharry, et al.
Acta Haematologica
|
June 2, 2024
Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions Trial
Alexandra Power-Hays, Ruth Namazzi, Charles Kato, et al.
Haematologica
|
April 4, 2020
Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes
Nathan Luebbering, Sheyar Abdullah, Dana Lounder, et al.
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine
|
March 28, 2019
A Pilot Study of Human Milk to Reduce Intestinal Inflammation After Bone Marrow Transplant
Pooja Khandelwal, Heidi Andersen, Lindsey Romick-Rosendale, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 149) with videos related to
Sort By:
Page
of 15
Pediatric Blood & Cancer
|
April 16, 2021
α4β7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host disease
Azada Ibrahimova, Stella M Davies, Adam Lane, et al.
British Journal of Clinical Pharmacology
|
April 13, 2025
The feasibility of pharmacokinetic-based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trial
Alexandra Power-Hays, Ruth Namazzi, Min Dong, et al.
Blood
|
November 14, 2022
Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa
Peter Olupot-Olupot, George Tomlinson, Thomas N Williams, et al.
Transplantation and Cellular Therapy
|
February 27, 2022
Abnormal Maximal and Submaximal Cardiopulmonary Exercise Capacity in Pediatric Stem Cell Transplant Recipients Despite Normal Standard Echocardiographic Parameters: A Pilot Study
Adam W Powell, Elaine M Urbina, Peace Madueme, et al.
Haematologica
|
December 24, 2025
Lipid dysregulation after hematopoietic stem cell transplant
Jane Koo, Lucille Langenberg, Xueheng Zhao, et al.
British Journal of Haematology
|
July 22, 2021
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial
Angela Rankine-Mullings, Marvin Reid, Deanne Soares, et al.
Translational Oncology
|
January 1, 2018
Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell Carcinoma
Trisha Wise-Draper, Arun Sendilnathan, Sarah Palackdharry, et al.
Acta Haematologica
|
June 2, 2024
Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions Trial
Alexandra Power-Hays, Ruth Namazzi, Charles Kato, et al.
Haematologica
|
April 4, 2020
Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes
Nathan Luebbering, Sheyar Abdullah, Dana Lounder, et al.
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine
|
March 28, 2019
A Pilot Study of Human Milk to Reduce Intestinal Inflammation After Bone Marrow Transplant
Pooja Khandelwal, Heidi Andersen, Lindsey Romick-Rosendale, et al.
Page
of 15